5 Best Real Estate and Realty Stocks To Buy According to Analysts

3. Ventas, Inc. (NYSE:VTR)

Average Analyst Price Target: $53.56

Upside Potential: 21.73%

Number of Hedge Fund Holders: 22

Ventas, Inc. (NYSE:VTR) is a health care REIT. It is based in Chicago, Illinois.

A total of 22 hedge funds were long Ventas, Inc. (NYSE:VTR) in the fourth quarter, with a total stake value of $427.4 million.

As of January 30, Deutsche Bank holds a $60 price target and a Buy rating on Ventas, Inc. (NYSE:VTR).

Here’s what Baron Funds said about Ventas, Inc. (NYSE:VTR) in its third-quarter 2023 investor letter:

“We remain optimistic about our health care REIT investment in Ventas, Inc. (NYSE:VTR). Health care real estate fundamentals are improving (rent increases and occupancy gains) against a backdrop of muted supply growth in the next two to three years due to increasing financing and construction costs and supply-chain challenges. The long-term demand outlook is favorable, driven in part by an aging population, which is expected to accelerate in the years ahead. Despite our optimism for long-term prospects for health care real estate, we are closely monitoring near-term expense headwinds combined with a slower-than-expected recovery in leasing and occupancy.